All common stock share and per share data for all periods prior to the quarterly period ending September 30, 2025 have been retroactively adjusted to reflect the 1-for-100 reverse stock split of the Company’s common stock and the decrease in the par value of the Company’s common stock from $0.0001 to $0.0000001 per share which became effective on August 18, 2025. See Note 2, “Summary of Significant Accounting Policies” for further information.

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash Flows From Operating Activities:
Net income (loss)	$ 169,626	$ (51,728)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Share-based compensation expense	2,066	4,556
Gain on change in fair value of SAFE and warrant liabilities	(5)	(3,184)
Loss on change in fair value of the Amended Brookfield Loan	1,800	12,445
Gain/Loss on change in fair value of the equity securities	(208,104)	0
Loss on Brookfield SAFE extinguishment	0	6,216
Change in fair value of Convertible Note	0	(42,980)
Gain on change in fair value of PIPE Warrant liability	0	3,400
Gain on partial lease termination	0	(60)
Provisions for losses on trade and other receivables and contract assets, net of recoveries	(518)	126
Depreciation of property, plant and equipment	1,901	1,835
Amortization of discount on debt security investment	0	(34)
Non-cash lease expense	510	917
Non-cash recognition of licensing revenue	(1,091)	(2,214)
Loss from equity method investees, net	17,462	9,867
Loss from disposal of property, plant and equipment	43	0
Unrealized (Gain)/Loss on net foreign exchange	(314)	649
Changes in operating assets and liabilities:
Accounts receivable, net	496	2,334
Contract assets	3,875	11,231
Accrued interest on debt investment	0	(83)
Other assets	(1,627)	1,377
Accounts payable and accrued salaries and wages	(2,750)	(882)
Contract liabilities	5,430	61
Operating lease liabilities	498	(877)
Other liabilities	46	4,213
Net cash used in operating activities	(10,656)	(42,815)
Cash Flows From Investing Activities:
Purchase of property, plant and equipment	(731)	(879)
Purchase of additional LanzaJet equity method investment	(3,000)	0
Proceeds from maturity of debt securities	0	12,408
Net cash (used in) provided by investing activities	(3,731)	11,529
Cash Flows From Financing Activities:
Proceeds from issuance of common stock	50,000	15,050
Issuance costs related to preferred stock and PIPE Warrant	0	(1,881)
Settlement of Forward Purchase Agreement	(2,000)	0
Issuance costs related to funding	(1,859)	0
Partial settlement of the Brookfield Loan	0	(12,500)
Proceeds from PIPE Warrant	0	24,950
Net cash provided by financing activities	46,141	25,619
Effects of currency translation on cash, cash equivalents and restricted cash	98	(425)
Net increase (decrease) in cash, cash equivalents and restricted cash	31,852	(6,092)
Cash, cash equivalents and restricted cash at beginning of period	17,051	45,737
Cash, cash equivalents and restricted cash at end of period	48,903	39,645
Supplemental disclosure of non-cash investing and financing activities:
Acquisition of property, plant and equipment under accounts payable	32	106
Issuance of the Brookfield Loan	0	6,216
Cashless issuance of equity for Convertible Notes	0	8,132
Non-cash change in lease liability on partial termination	0	13,025
Non-cash change in ROU assets on partial termination	$ 0	$ (13,085)

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 44,977	$ 13,164
Trade and other receivables, net of allowance	9,612	9,527
Contract assets, net of allowance	2,525	6,541
Other current assets	12,129	10,456
Total current assets	69,243	39,688
Property, plant and equipment, net	15,861	17,128
Right-of-use assets	13,868	14,378
Equity method investment	0	13,272
Equity security investment	223,094	14,990
Other non-current assets	626	751
Total assets	322,692	100,207
Current liabilities:
Accounts payable	7,330	10,869
Other accrued liabilities	10,710	10,278
Warrants	6	11
Fixed Maturity Consideration and current FPA Put Option liability	0	4,123
Contract liabilities	5,853	423
Accrued salaries and wages	2,664	1,843
Current lease liabilities	385	176
Other liabilities	963	0
Total current liabilities	27,911	27,723
Non-current lease liabilities	15,717	16,388
Non-current contract liabilities	5,725	5,896
FPA Put Option liability	0	30,015
Brookfield Loan liability	12,700	10,900
Other long-term liabilities	3	8
Total liabilities	62,056	90,930
Commitments and Contingencies (Note 15)
Mezzanine Equity
Convertible preferred stock, $0.0001 par value; 20,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 0 and 20,000,000 shares issued as of June 30, 2026 and December 31, 2025, respectively; and 0 and 20,000,000 shares outstanding as of June 30, 2026 and December 31, 2025, respectively	0	2
Preferred stock - additional paid-in capital	0	13,167
Total mezzanine equity	0	13,169
Shareholders’ Equity/(Deficit)
Common stock, $0.0000001 par value, 25,800,000 shares authorized as of June 30, 2026 and December 31, 2025; 13,089,163 and 2,320,511 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively	23	23
Additional paid-in capital	1,108,713	1,013,195
Accumulated other comprehensive income	828	1,444
Accumulated deficit	(848,928)	(1,018,554)
Total shareholders’ equity/(deficit)	260,636	(3,892)
Total liabilities, mezzanine equity and shareholders' equity	$ 322,692	$ 100,207